By: Chris Kavila
The following mesothelioma research findings were reported in a recent issue of the Journal of Clinical Oncology. Mesothelioma researchers have reported that combining Tomudex '(raltitrexed) and Platinol (cisplatin) has shown impressive results in improved survival of patients with rare malignant pleural mesothelioma as a result of normal exposure to asbestos.
According to the mesothelioma research findings reported in the paper, the combination treatment significantly improves patient survival compared to the use of Platinol alone.
These research results of a randomized phase III mesothelioma.
Patients with this rare mesothelioma usually experience shortness of breath, cough, pain, fatigue and anorexia. This new mesothelioma research findings are encouraging, because this type of cancer has proven resistant to most treatments, including surgery, chemotherapy alone, and even with the radiation.
What complicates matters further, in general, is that patients are generally unaware that they suffer from malignant pleural mesothelioma until the disease has reached an advanced stage where treatment with surgery or radiotherapy is no longer a viable option .
Thus the identification of treatments that may improve survival and quality of life of patients, this research promises mesothelioma, is so important.
According to the mesothelioma research findings reported in the paper, the combination treatment significantly improves patient survival compared to the use of Platinol alone.
These research results of a randomized phase III mesothelioma.
Patients with this rare mesothelioma usually experience shortness of breath, cough, pain, fatigue and anorexia. This new mesothelioma research findings are encouraging, because this type of cancer has proven resistant to most treatments, including surgery, chemotherapy alone, and even with the radiation.
What complicates matters further, in general, is that patients are generally unaware that they suffer from malignant pleural mesothelioma until the disease has reached an advanced stage where treatment with surgery or radiotherapy is no longer a viable option .
Thus the identification of treatments that may improve survival and quality of life of patients, this research promises mesothelioma, is so important.
